Repetitive transcranial magnetic stimulation (rTMS): New tool, new therapy and new hope for ADHD

Current Medical Research and Opinion

Volumn 19, Issue 2, 2003, Pages 125-130

  Acosta, Maria T ^a   Leon Sarmiento, Fidias E ^b,c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ADHD; Dopamine; Methylphenidate; Pharmacology; TMS

Indexed keywords

DOPAMINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; CEREBELLUM; DEVELOPMENTAL DISORDER; DOPAMINERGIC SYSTEM; FRONTAL LOBE; HUMAN; NEUROBIOLOGY; RIGHT HEMISPHERE; SAFETY; SENSORIMOTOR FUNCTION; STRIATE CORTEX; TRANSCRANIAL MAGNETIC STIMULATION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; ELECTROMAGNETICS; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0038297517     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079903125001541     Document Type: Article

References (58)

1. Acosta MT. Clinical, epidemiological and therapeutical aspects in ADHD. Rev Neurol 2000;31:221
2. Acosta MT. Neurobiological aspects in ADHD: an update. Rev Neuropsicol Neuropsiquiat Neuroc 2000;1:3-19
3. Castellanos XC, Acosta MT. ADHD as expression of functional organic disorder. Rev Neurologia 2002;35:1-11
4. Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME. Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry 1997;36:1222-7
5. Acosta MT, Leon-Sarmiento FE. ADHD and alcohol abuse in parents. Ann Neurol 2002;52(Suppl 1):127
6. Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil M, Burke LB. Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry 1999;38:557-5
7. Acosta MT, Montañez P, Leon-Sarmiento FE. Half brain but not half function. Lancet 2002;360:643
8. Hallett M. Functional reorganization after lesions of the human brain: studies with transcranial magnetic stimulation. Rev Neurol (Paris) 2001;157:822-6
9. Leon-Sarmiento FE. Electrodiagnostico: EEG, PE, EMG, Estimulacion Magnetica. In: Uribe CS, Arana A, Lorenzana P, eds. Neurologia. Medellin: C1B 2002:34-66
10. Ucles P, Serrano JL, Rosa F. Central conduction time of magnetic brain stimulation in attention-deficit hyperactivity disorder. J Child Neurol 2000;15:723-8
11. Moll GH, Heinrich H, Trott G, Wirth S, Rothenberger A. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Lett 2000;284:121-5
12. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001;21:RC157
13. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, et al. Quantitative brain magnetic resonance imaging in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1996;53:607-16
14. Hynd GW, Hern KL, Novey ES, Eliopulos D, Marshall R, Gonzalez JJ, et al. Attention deficit hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993;8:339-47
15. Mataró M, García-Sánchez C, Junqué C, Estévez-González A, Pujol J. Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioral measures. Arch Neurol 1997;54:963-8
16. Overmeyer S, Bullmore ET, Suckling J, Simmons A, Williams SC, Santosh PJ, et al. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol Med 2001;31:1425-35
17. Mostofsky SH, Reiss AL, Lockhart P, Denckla MB. Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J Child Neurol 1998;13:434-9
18. Castellanos FX, Giedd JN, Berquin PC, Walter JM, Sharp W, Tran T, et al. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001;58:289-95
19. Wender PH. Some speculations concerning a possible biochemical basis of minimal brain dysfunction. Ann NY Acad Sci 1973;205:18-28
20. Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996;35:264-72
21. Acosta MT. Neurobiological and neuropsychological implications from pharmacological treatment of attention deficit hyperactivity disorder. Thesis for obtaining the degree of specialist in child neuropsychology. European Graduate School of Child Neuropsychology and Vrije University. Duivendrecht/ Amsterdam, Netherlands, 1997
22. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci 1998;18:5901-7
23. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 2000;285:107-10
24. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001;158:1052-57
25. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997;2:311-3
26. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, et al. Dopamine genes and ADHD. Neurosci Biobehav Rev 2000;24:21-5
27. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997;121:65-94
28. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-81
29. Graybiel AM. The basal ganglia and chunking of action repertoires. Neurobiol Learn Mem 1998;70:119-36
30. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance imaging study. Proc Natl Acad Sci USA 1998;95:14494-9
31. Rapoport JL, Buchsbaum MS, Zahn TP, Weingartner H, Ludlow C, Mikkelsen EJ. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science 1978; 199:560-3
32. Lou HC, Henriksen L, Bruhn P. Focal cerebral dysfunction in developmental learning disabilities. Lancet 1990;335:8-11
33. Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990;323:1361-6
34. Solanto MV. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience. Behav Brain Res 2002; 130:65-71
35. Baving L, Laucht M, Schmidt MH. Atypical frontal brain activation in ADHD: preschool and elementary school boys and girls. J Am Acad Child Adolesc Psychiatry 1999;38:1363-71
36. Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SC, Simmons A, et al. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry 1999;156:891-6
37. Rapport MD, Moffitt C. Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects. Clin Psychol Rev 2002;22:1107-31
38. The MTA Cooperative Group. Multimodal treatments study of children with ADHD: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-86
39. George MS, Sallee FR, Nahas Z, Oliver NC, Wassermann EM. Transcranial magnetic stimulation (TMS) as a research tool in Tourette syndrome and related disorders. Adv Neurol 2001;85:225-35
40. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 2000;406:147-150
41. Pascual-Leone A. The brain that plays music and is changed by it. Ann N Y Acad Sci 2001;930:315-29
42. Wassermann EM, Lisanby SH. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol 2001;112:1367-77
43. Mally J, Stone TW. Therapeutic and "dose-dependent" effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease. J Neurosci Res 1999;57:935-40
44. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 2002;5:73-103
45. Lin KL, Pascual-Leone A. Transcranial magnetic stimulation and its applications in children. Chang Gung Med J 2002;25:424-36
46. Shimamoto H, Takasaki K, Shigemori M, Imaizumi T, Ayabe M, Shoji H. Therapeutic effect and mechanism of repetitive transcranial magnetic stimulation in Parkinson's disease. J Neurol 200;248 (Suppl 3):48-52
47. Moll GH, Heinrich H, Trott G, Wirth S, Rothenberger A. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Lett 2000;284:121-5
48. Garcia-Toro M, Saiz-Ruiz J, Talavera JA, Blanco C. Chaos theories and therapeutic commonalities among depression, Parkinson's disease, and cardiac arrhythmias. Comp Psychiatry 1999;40:238-44
49. Arnsten AF, Steere JC, Hunt RD. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996;53:448-55
50. Seeman P, Madras B. Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behav Brain Res 2002;130:79-83
51. Levkovitz Y, Grisaru N, Segal M. Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus. Neuropsychopharmacology 2001;24:608-16
52. Aspide R, Gironi Carnevale UA, Sergeant JA, Sadile AG. Non-selective attention and nitric oxide in putative animal models of Attention-deficit hyperactivity disorder. Behav Brain Res 1998;95:123-33
53. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998;108:1-16
54. Leon-Sarmiento FE, Hanft RT, Bara W, Hallett M, Wassermann E. The influence of visual activation tasks on motor cortex excitability studied with transcranial magnetic stimulation, 2002. www.abstract-on-line.com/abstracts/AAN
55. Omura Y, Losco BM, Takeshige C. Non-invasive evaluation of the effects of opening and closing of eyes, and of exposure to a minute light beam, as well as to electrical or magnetic field on the melatonin, serotonin, & other neuro-transmitters of human pineal gland representation areas & the heart. Acupunct Electrother Res 1993;18:125-51
56. George MS, Nahas Z, Bohning DE, et al. TMS and neuroimaging. In: George M and Belmaker RH, eds. Transcraneal Magnetic Stimulation in Neuropsychiatry. Washington DC: American Psychiatric Press 2000:253-68
57. Kim BN, Lee JS, Cho SC, Lee DS. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder. Yonsei Med J 2001;42:19-29
58. Garvey MA, Kaczynski KJ, Becker DA, Bartko JJ. Subjective reactions of children to single-pulse transcranial magnetic stimulation. J Child Neurol 2001;16:891-4